Patient and central venous catheter related risk factors for blood stream infections in children receiving chemotherapy

Pediatric Blood and Cancer

Volumn 62, Issue 3, 2015, Pages 471-476

  Yacobovich, Joanne ^a   Ben Ami, Tal ^b   Abdalla, Tameemi ^b   Tamary, Hannah ^a   Goldstein, Gal ^a   Weintraub, Michael ^b   Yaniv, Isaac ^a   Toren, Amos ^a   Kenet, Gili ^a   Revel Vilk, Shoshana ^b  

^a TEL AVIV UNIVERSITY   (Israel)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Blood stream infection; Central venous catheter; Chemotherapy; Children; Risk factors

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CATHETER INFECTION; CATHETER OCCLUSION; CENTRAL VENOUS CATHETER; CENTRAL VENOUS CATHETER OCCLUSION; CENTRAL VENOUS CATHETERIZATION; CHILD; CHILDHOOD CANCER; COAGULASE NEGATIVE STAPHYLOCOCCUS; DEMOGRAPHY; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HOST; HUMAN; INFECTION RATE; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MEDICAL DEVICE COMPLICATION; MYELOID LEUKEMIA; PERIPHERAL VENOUS CATHETER; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SCHOOL CHILD; ADOLESCENT; ADULT; ADVERSE EFFECTS; AGE; CLINICAL TRIAL; INCIDENCE; INFANT; LEUKEMIA, MYELOID; MULTICENTER STUDY; PRESCHOOL CHILD; STAPHYLOCOCCAL INFECTIONS;

ADOLESCENT; ADULT; AGE FACTORS; ANTINEOPLASTIC AGENTS; CENTRAL VENOUS CATHETERS; CHILD; CHILD, PRESCHOOL; HUMANS; INCIDENCE; INFANT; LEUKEMIA, MYELOID; PROSPECTIVE STUDIES; RISK FACTORS; STAPHYLOCOCCAL INFECTIONS;

EID: 84921334088     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.25281     Document Type: Article

References (25)

1. Cecinati V, Brescia L, Tagliaferri L, Giordano P, Esposito S. Catheter-related infections in pediatric patients with cancer. Eur J Clin Microbiol Infect Dis 2012; 31:2869-2877.
2. Iannacci L, Piomelli S. Supportive care for children with cancer. Guidelines of the Childrens Cancer Study Group. Use of venous access lines. Am J Pediatr Hematol Oncol 1984; 6:277-281.
3. Rinke ML, Milstone AM, Chen AR, Mirski K, Bundy DG, Colantuoni E, Pehar M, Herpst C, Miller MR. Ambulatory pediatric oncology CLABSIs: Epidemiology and risk factors. Pediatr Blood Cancer 2013; 60:1882-1889.
4. Revel-Vilk S, Yacobovich J, Tamary H, Goldstein G, Nemet S, Weintraub M, Paltiel O, Kenet G. Risk factors for central venous catheter thrombotic complications in children and adolescents with cancer. Cancer 2010; 116:4197-4205.
5. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008; 36:309-332.
6. Abramson JH. WINPEPI (PEPI-for-Windows): Computer programs for epidemiologists. Epidemiol Perspect Innov 2004; 1:6.
7. Lech-Maranda E, Seweryn M, Giebel S, Holowiecki J, Piatkowska-Jakubas B, Wegrzyn J, Skotnicki A, Kielbinski M, Kuliczkowski K, Paluszewska M, Jedrzejczak WW, Dutka M, Hellmann A, Flont M, Zdziarska B, Palynyczko G, Konopka L, Szpila T, Gawronski K, Sulek K, Sokolowski J, Kloczko J, Warzocha K, Robak T. Infectious complications in patients with acute myeloid leukemia treated according to the protocol with daunorubicin and cytarabine with or without addition of cladribine. A multicenter study by the Polish Adult Leukemia Group (PALG). Int J Infect Dis 2010; 14:e132-e140.
8. Sung L, Buxton A, Gamis A, Woods WG, Alonzo TA. Life-threatening and fatal infections in children with acute myeloid leukemia: A report from the Children's Oncology Group. J Pediatr Hematol Oncol 2012; 34:e30-e35.
9. Lewis V, Yanofsky R, Mitchell D, Dix D, Ethier MC, Gillmeister B, Johnston D, Michon B, Stobart K, Portwine C, Silva M, Cellot S, Price V, Bowes L, Zelcer S, Brossard J, Beyene J, Sung L. Predictors and outcomes of viridans group streptococcal infections in pediatric acute myeloid leukemia: From the Canadian infections in AML research group. Pediatr Infect Dis J 2014; 33:126-129.
10. Allen RC, Holdsworth MT, Johnson CA, Chavez CM, Heideman RL, Overturf G, Lemon D, Hunt WC, Winter SS. Risk determinants for catheter-associated blood stream infections in children and young adults with cancer. Pediatr Blood Cancer 2008; 51:53-58.
11. Doganis D, Asmar B, Yankelevich M, Thomas R, Ravindranath Y. Predictive factors for blood stream infections in children with cancer. Pediatr Hematol Oncol 2013; 30:403-415.
12. Sung L, Zaoutis T, Ullrich NJ, Johnston D, Dupuis L, Ladas E. Children's Oncology Group's 2013 blueprint for research: Cancer control and supportive care. Pediatr Blood Cancer 2013; 60:1027-1030.
13. Kelly MS, Conway M, Wirth KE, Potter-Bynoe G, Billett AL, Sandora TJ. Microbiology and risk factors for central line-associated bloodstream infections among pediatric oncology outpatients: A single institution experience of 41 cases. J Pediatr Hematol Oncol 2013; 35:e71-e76.
14. Newman N, Issa A, Greenberg D, Kapelushnik J, Cohen Z, Leibovitz E. Central venous catheter-associated bloodstream infections. Pediatr Blood Cancer 2012; 59:410-414.
15. Pinon M, Bezzio S, Tovo PA, Fagioli F, Farinasso L, Calabrese R, Marengo M, Giacchino M. A prospective 7-year survey on central venous catheter-related complications at a single pediatric hospital. Eur J Pediatr 2009; 168:1505-1512.
16. Krishnaiah A, Soothill J, Wade A, Mok QQ, Ramnarayan P. Central venous catheter-associated bloodstream infections in a pediatric intensive care unit: Effect of the location of catheter insertion. Pediatr Crit Care Med 2012; 13:e176-e180.
17. Lim MY, Al-Kali A, Ashrani AA, Begna KH, Elliott MA, Hogan WJ, Hook CC, Kaufmann SH, Letendre L, Litzow MR, Patnaik MS, Pardanani A, Tefferi A, Wolanskyj AP, Grill DE, Pruthi RK. Comparison of complication rates of Hickman((R)) catheters versus peripherally inserted central catheters in patients with acute myeloid leukemia undergoing induction chemotherapy. Leuk Lymphoma 2013; 54:1263-1267.
18. Fratino G, Molinari AC, Parodi S, Longo S, Saracco P, Castagnola E, Haupt R. Central venous catheter-related complications in children with oncological/hematological diseases: An observational study of 418 devices. Ann Oncol 2005; 16:648-654.
19. Journeycake JM, Buchanan GR. Thrombotic complications of central venous catheters in children. Curr Opin Hematol 2003; 10:369-374.
20. Rowan CM, Miller KE, Beardsley AL, Ahmed SS, Rojas LA, Hedlund TL, Speicher RH, Nitu ME. Alteplase use for malfunctioning central venous catheters correlates with catheter-associated bloodstream infections. Pediatr Crit Care Med 2013; 14:306-309.
21. Schoot RA, van Dalen EC, van Ommen CH, van de Wetering MD. Antibiotic and other lock treatments for tunnelled central venous catheter-related infections in children with cancer. Cochrane Database Syst Rev 2013; 6:CD008975.
22. Arora RS, Roberts R, Eden TO, Pizer B. Interventions other than anticoagulants and systemic antibiotics for prevention of central venous catheter-related infections in children with cancer. Cochrane Database Syst Rev 2010; 12:CD007785.
23. van Rooden CJ, Schippers EF, Guiot HF, Barge RM, Hovens MM, van der Meer FJ, Rosendaal FR, Huisman MV. Prevention of coagulase-negative staphylococcal central venous catheter-related infection using urokinase rinses: A randomized double-blind controlled trial in patients with hematologic malignancies. J Clin Oncol 2008; 26:428-433.
24. Dunn AL, Abshire TC. Recombinant tissue plasminogen activator may reduce frequency of central venous access device infection in hemophilia patients undergoing immune tolerance therapy. Pediatr Blood Cancer 2008; 50:627-629.
25. Tomlinson D, Mermel LA, Ethier MC, Matlow A, Gillmeister B, Sung L. Defining bloodstream infections related to central venous catheters in patients with cancer: A systematic review. Clin Infect Dis 2011; 53:697-710.